Q2 2025 · 13F-HR
Finepoint Capital LPholdings as filed
Filed 2025-08-13 · accession 0000904454-25-000412
$1.36B
Reported value
10
Positions
2025-06-30
Period end
The Brief · Finepoint Capital LP · Q2 2025
AI · grounded in 13F
Finepoint Capital LP established a new position in SPY valued at $725.0M. The fund also initiated a new stake in QXO for $455.6M and added IWM with a $126.2M investment. Other new positions include [[stock:LLYVK*]], SLDB, and ANNA.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $725.0M | 53.5% | 1,173,500 | PUT | SOLE |
| 82846H405 | QXO | QXO INC | $455.6M | 33.6% | 21,152,868 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $126.2M | 9.31% | 585,000 | PUT | SOLE |
| 531229722 | LLYVK* | LIBERTY MEDIA CORP DEL | $43.6M | 3.22% | 537,051 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $4.7M | 0.35% | 961,251 | Common | SOLE |
| 01444V103 | ANNA | ALEANNA INC | $199,562 | 0.01% | 27,717 | Common | SOLE |
| 01444V111 | ANNAW | ALEANNA INC | $115,150 | 0.01% | 490,000 | Common | SOLE |
| G6202B119 | MNYWW | MONEYHERO LTD | $41,886 | 0.00% | 895,000 | Common | SOLE |
| G9845F117 | LSBWF | LAKESHORE BIOPHARMA CO LTD | $19,551 | 0.00% | 489,999 | Common | SOLE |
| 320703309 | — | CALIDI BIOTHERAPEUTICS INC | $2,875 | 0.00% | 12,499 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.